Edition:
India

Kura Oncology Inc (KURA.OQ)

KURA.OQ on NASDAQ Stock Exchange Global Select Market

18.50USD
22 Jun 2018
Change (% chg)

$-0.10 (-0.54%)
Prev Close
$18.60
Open
$18.80
Day's High
$18.80
Day's Low
$18.20
Volume
391,722
Avg. Vol
81,676
52-wk High
$24.00
52-wk Low
$5.90

Latest Key Developments (Source: Significant Developments)

Kura Oncology files for mixed shelf offering of up to $200 mln - SEC filing‍​
Friday, 10 Nov 2017 

Nov 9 (Reuters) - Kura Oncology Inc :Kura Oncology Inc - files for mixed shelf offering of up to $200 million - SEC filing‍​.  Full Article

Kura Oncology reports third quarter 2017 financial results
Wednesday, 8 Nov 2017 

Nov 7 (Reuters) - Kura Oncology Inc ::Kura Oncology reports third quarter 2017 financial results and provides corporate update.Q3 loss per share $0.38.Q3 earnings per share view $-0.37 -- Thomson Reuters I/B/E/S.  Full Article

KURA ONCOLOGY ‍CONFIRMS PARTIAL RESPONSES OBSERVED IN PATIENTS WITH HRAS MUTANT HNSCC IN TRIAL
Friday, 27 Oct 2017 

Oct 27 (Reuters) - Kura Oncology Inc :KURA ONCOLOGY LEAD CANDIDATE TIPIFARNIB SHOWS DURABLE ANTI-TUMOR ACTIVITY IN HRAS MUTANT HEAD AND NECK CANCER IN AACR-NCI-EORTC UPDATE.‍CONFIRMED PARTIAL RESPONSES OBSERVED IN FOUR OUT OF SIX PATIENTS WITH HRAS MUTANT HNSCC IN TRIAL​.BASED ON POSITIVE RESULTS FROM PHASE 2 TRIAL, CO PLANS TO INITIATE A REGISTRATION-ENABLING STUDY IN HRAS MUTANT HNSCC IN 2018​.  Full Article

Kura Oncology Q2 net loss $6.7 million
Thursday, 11 Aug 2016 

Kura Oncology Inc : Kura Oncology reports second quarter 2016 financial results . Net loss for Q2 of 2016 was $6.7 million, or $0.36 per share .Says IND Submission For Erk Inhibitor, Ko-947, is anticipated in second half of 2016.  Full Article

BRIEF-Kura Oncology Reports Qtrly Loss Per Share Of $0.46

* KURA ONCOLOGY REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE